The CDC said it is still reviewing a separate ACIP recommendation related to doses administered after the birth-dose period. In a 6-4 vote, the panel recommended that parents and clinicians discuss ...

The CDC’s Advisory Committee on Immunization Practices' move away from recommending routine hepatitis B vaccination at birth is being treated as either a triumph of “medical freedom” or a looming ...

The recent controversial decision of the Advisory Committee on Immunization Practices (ACIP) in the US to halt universal newborn vaccination with the ...

Members of the Advisory Committee on Immunization Practices (ACIP) voted 8-3 to instead recommend a shared clinical decision-making process for infants born to mothers who test negative for hepatitis ...

While the United States has dropped its long-standing policy of a universal Hepatitis B birth-dose for newborns, Malaysian ...

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company developing targeted oligonucleotide therapies for functional cure of chronic ...

Objective This study aims to assess the prevalence of cancer risk factors in China’s working population and provide evidence for formulating more targeted workplace cancer prevention strategies.

ABSTRACT: Hepatitis B surface antigen prevalence in populations of blood donors in Cameroon is estimated at 6%-16%. As such, the Objective of this study was to ...

Background PD-1 blockade has emerged as a promising approach for functional cure of chronic hepatitis B (CHB). Objective This study aimed to evaluate the safety profile of anti-PD-1 antibody (αPD-1), ...

Precision BioSciences offers high-risk, high-reward potential, trading below cash with key HBV and DMD data catalysts ...